First human test of kidney drug begins in healthy volunteers
NCT ID NCT03719443
First seen May 14, 2026 · Last updated May 22, 2026 · Updated 3 times
Summary
This early-stage study tested a new drug called VIS649 in healthy adults to see if it is safe and how the body processes it. The drug is designed to target a protein linked to IgA nephropathy, a kidney disease. 51 healthy volunteers received either the drug or a placebo. This study does not offer treatment for any disease, but gathers important safety information for future research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNOGLOBULIN A NEPHROPATHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
California Clinical Trials Medical Group
Glendale, California, 91206, United States
Conditions
Explore the condition pages connected to this study.